Skip to main content
SpringerLink
Log in

61-Year-Old Male with Joint Stiffness

  • Chapter
  • First Online:
Clinical Cases in Psoriasis

Part of the book series: Clinical Cases in Dermatology ((CLIDADE))

  • 500 Accesses

Abstract

Psoriatic arthritis (PsA) is a chronic, inflammatory, seronegative spondyloarthropathy associated with psoriasis. Symptoms of PsA improve with activity and include tenderness, stiffness, swelling, and reduced range of motion of the involved joints. If left untreated, PsA may lead to permanent joint damage. Biologics such as TNF inhibitors, IL-12/23 inhibitor, and IL-17 inhibitors are effective in both improving symptoms and inhibiting radiographic joint disease progression in PsA.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Gottlieb AB, Mease PJ, Mark Jackson J, Eisen D, Amy Xia H, Asare C, Stevens SR. Clinical characteristics of psoriatic arthritis and psoriasis in dermatologists’ offices. J Dermatolog Treat. 2006;17(5):279–87. https://doi.org/10.1080/09546630600823369.

    Article  PubMed  Google Scholar 

  2. Chang CA, Gottlieb AB, Lizzul PF. Management of psoriatic arthritis from the view of the dermatologist. Nat Rev Rheumatol. 2011;7(10):588–98. https://doi.org/10.1038/nrrheum.2011.125.

    Article  CAS  PubMed  Google Scholar 

  3. Alinaghi F, Calov M, Kristensen LE, Gladman DD, Coates LC, Jullien D, et al. Prevalence of psoriatic arthritis in patients with psoriasis: a systematic review and meta-analysis of observational and clinical studies. J Am Acad Dermatol. 2018;80:251–265.e19. https://doi.org/10.1016/j.jaad.2018.06.027.

    Article  PubMed  Google Scholar 

  4. Cohen MR, Reda DJ, Clegg DO. Baseline relationships between psoriasis and psoriatic arthritis: analysis of 221 patients with active psoriatic arthritis. Department of Veterans Affairs Cooperative Study Group on Seronegative Spondyloarthropathies. J Rheumatol. 1999;26(8):1752–6.

    CAS  PubMed  Google Scholar 

  5. Queiro R, Morante I, Cabezas I, Acasuso B. HLA-B27 and psoriatic disease: a modern view of an old relationship. Rheumatology (Oxford). 2016;55(2):221–9. https://doi.org/10.1093/rheumatology/kev296.

    Article  CAS  Google Scholar 

  6. Helliwell P. Psoriasis and psoriatic arthritis: an integrated approach. Berlin: Springer; 2005.

    Google Scholar 

  7. Reich K, Kruger K, Mossner R, Augustin M. Epidemiology and clinical pattern of psoriatic arthritis in Germany: a prospective interdisciplinary epidemiological study of 1511 patients with plaque-type psoriasis. Br J Dermatol. 2009;160(5):1040–7. https://doi.org/10.1111/j.1365-2133.2008.09023.x.

    Article  CAS  PubMed  Google Scholar 

  8. Gladman DD, Antoni C, Mease P, Clegg DO, Nash P. Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Ann Rheum Dis. 2005;64(Suppl 2):ii14–7. https://doi.org/10.1136/ard.2004.032482.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Brockbank JE, Stein M, Schentag CT, Gladman DD. Dactylitis in psoriatic arthritis: a marker for disease severity? Ann Rheum Dis. 2005;64(2):188–90. https://doi.org/10.1136/ard.2003.018184.

    Article  CAS  PubMed  Google Scholar 

  10. Mease PJ, Armstrong AW. Managing patients with psoriatic disease: the diagnosis and pharmacologic treatment of psoriatic arthritis in patients with psoriasis. Drugs. 2014;74(4):423–41. https://doi.org/10.1007/s40265-014-0191-y.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Chou R, Helfand M, Peterson K, Dana T, Roberts C. Drug class review: cyclo-oxygenase (COX)-2 inhibitors and non-steroidal anti-inflammatory drugs (NSAIDs): final report update 3. Portland (OR); 2006.

    Google Scholar 

  12. Brodell RT, Williams L. A corticosteroid-induced flare of psoriasis. How to control or, better yet, avoid. Postgrad Med. 1999;106(7):31–2. https://doi.org/10.3810/pgm.1999.12.813.

    Article  CAS  PubMed  Google Scholar 

  13. Mrowietz U, Domm S. Systemic steroids in the treatment of psoriasis: what is fact, what is fiction? J Eur Acad Dermatol Venereol. 2013;27(8):1022–5. https://doi.org/10.1111/j.1468-3083.2012.04656.x.

    Article  CAS  PubMed  Google Scholar 

  14. Coates LC, Gossec L, Ramiro S, Mease P, van der Heijde D, Smolen JS, et al. New GRAPPA and EULAR recommendations for the management of psoriatic arthritis. Rheumatology (Oxford). 2017;56(8):1251–3. https://doi.org/10.1093/rheumatology/kew390.

    Article  Google Scholar 

  15. Gossec L, Smolen JS, Ramiro S, de Wit M, Cutolo M, Dougados M, et al. European League Against rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update. Ann Rheum Dis. 2016;75(3):499–510. https://doi.org/10.1136/annrheumdis-2015-208337.

    Article  CAS  PubMed  Google Scholar 

  16. Gossec L, Smolen JS, Gaujoux-Viala C, Ash Z, Marzo-Ortega H, van der Heijde D, et al. European League Against rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies. Ann Rheum Dis. 2012;71(1):4–12. https://doi.org/10.1136/annrheumdis-2011-200350.

    Article  CAS  PubMed  Google Scholar 

  17. Ritchlin CT, Kavanaugh A, Gladman DD, Mease PJ, Helliwell P, Boehncke WH, et al. Treatment recommendations for psoriatic arthritis. Ann Rheum Dis. 2009;68(9):1387–94. https://doi.org/10.1136/ard.2008.094946.

    Article  CAS  PubMed  Google Scholar 

  18. Mease PJ, Gladman DD, Ritchlin CT, Ruderman EM, Steinfeld SD, Choy EH, et al. Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: results of a double-blind, randomized, placebo-controlled trial. Arthritis Rheum. 2005;52(10):3279–89. https://doi.org/10.1002/art.21306.

    Article  CAS  PubMed  Google Scholar 

  19. Alwawi EA, Krulig E, Gordon KB. Long-term efficacy of biologics in the treatment of psoriasis: what do we really know? Dermatol Ther. 2009;22(5):431–40. https://doi.org/10.1111/j.1529-8019.2009.01259.x.

    Article  PubMed  Google Scholar 

  20. Gniadecki R, Kragballe K, Dam TN, Skov L. Comparison of drug survival rates for adalimumab, etanercept and infliximab in patients with psoriasis vulgaris. Br J Dermatol. 2011;164(5):1091–6. https://doi.org/10.1111/j.1365-2133.2011.10213.x.

    Article  CAS  PubMed  Google Scholar 

  21. Kavanaugh A, McInnes IB, Mease PJ, Hall S, Chinoy H, Kivitz AJ, et al. Efficacy of subcutaneous secukinumab in patients with active psoriatic arthritis stratified by prior tumor necrosis factor inhibitor use: results from the randomized placebo-controlled FUTURE 2 study. J Rheumatol. 2016;43(9):1713–7. https://doi.org/10.3899/jrheum.160275.

    Article  PubMed  Google Scholar 

  22. Kavanaugh A, Mease PJ, Reimold AM, Tahir H, Rech J, Hall S, et al. Secukinumab for long-term treatment of psoriatic arthritis: a two-year followup from a phase III, randomized, double-blind placebo-controlled Study. Arthritis Care Res (Hoboken). 2017;69(3):347–55. https://doi.org/10.1002/acr.23111.

    Article  CAS  Google Scholar 

  23. Kavanaugh A, Ritchlin C, Rahman P, Puig L, Gottlieb AB, Li S, et al. Ustekinumab, an anti-IL-12/23 p40 monoclonal antibody, inhibits radiographic progression in patients with active psoriatic arthritis: results of an integrated analysis of radiographic data from the phase 3, multicentre, randomised, double-blind, placebo-controlled PSUMMIT-1 and PSUMMIT-2 trials. Ann Rheum Dis. 2014;73(6):1000–6. https://doi.org/10.1136/annrheumdis-2013-204741.

    Article  CAS  PubMed  Google Scholar 

  24. Rahman P, Puig L, Gottlieb AB, Kavanaugh A, McInnes IB, Ritchlin C, et al. Ustekinumab treatment and improvement of physical function and health-related quality of life in patients with psoriatic arthritis. Arthritis Care Res (Hoboken). 2016;68(12):1812–22. https://doi.org/10.1002/acr.23000.

    Article  CAS  Google Scholar 

  25. van der Heijde D, Gladman DD, Kishimoto M, Okada M, Rathmann SS, Moriarty SR, et al. Efficacy and safety of Ixekizumab in patients with active psoriatic arthritis: 52-week results from a phase III Study (SPIRIT-P1). J Rheumatol. 2018;45(3):367–77. https://doi.org/10.3899/jrheum.170429.

    Article  CAS  PubMed  Google Scholar 

  26. Combe B, Behrens F, McHugh N, Brock F, Kerkmann U, Kola B, Gallo G. Comparison of etanercept monotherapy and combination therapy with methotrexate in psoriatic arthritis: results from 2 clinical trials. J Rheumatol. 2016;43(6):1063–7. https://doi.org/10.3899/jrheum.151290.

    Article  CAS  PubMed  Google Scholar 

  27. Kavanaugh A, Mease PJ, Gomez-Reino JJ, Adebajo AO, Wollenhaupt J, Gladman DD, et al. Longterm (52-week) results of a phase III randomized, controlled trial of apremilast in patients with psoriatic arthritis. J Rheumatol. 2015;42(3):479–88. https://doi.org/10.3899/jrheum.140647.

    Article  CAS  PubMed  Google Scholar 

  28. Salvarani C, Macchioni P, Olivieri I, Marchesoni A, Cutolo M, Ferraccioli G, et al. A comparison of cyclosporine, sulfasalazine, and symptomatic therapy in the treatment of psoriatic arthritis. J Rheumatol. 2001;28(10):2274–82.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Frank H. Netter MD School of Medicine at Quinnipiac University, North Haven, CT, USA

    Kevin K. Wu

  2. Eastern Virginia Medical School, Norfolk, VA, USA

    Michael P. Lee

  3. Founder and CEO, Dermatology Research and Education Foundation, Irvine, CA, USA

    Jashin J. Wu

Authors
  1. Kevin K. Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael P. Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jashin J. Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Founder and CEO, Dermatology Research and Education Foundation, Irvine, CA, USA

    Jashin J. Wu

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Wu, K.K., Lee, M.P., Wu, J.J. (2019). 61-Year-Old Male with Joint Stiffness. In: Wu, J. (eds) Clinical Cases in Psoriasis. Clinical Cases in Dermatology. Springer, Cham. https://doi.org/10.1007/978-3-030-18772-9_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-18772-9_9

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-18771-2

  • Online ISBN: 978-3-030-18772-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation